Enalapril is an angiotensin-converting enzyme inhibitor (ACE-I) used for the treatment of hypertension (including primary, renal, renovascular, and malignant hypertension), congestive heart failure (particularly in patients unresponsive to digitalis and diuretics), and long-term management of high-renin or hypercalcemic hypertension. It is also used in patients who are intolerant to captopril. Enalapril can be combined with hydrochlorothiazide (as the fixed-dose combination Vaseretic) to enhance antihypertensive efficacy by 15–30%. Additionally, it is applied in the management of chronic allograft nephropathy (in combination with Bailing capsules), attenuation of renal interstitial fibrosis via downregulation of connective tissue growth factor, and improvement of aortic remodeling (especially when co-administered with irbesartan). It is also used in combination with metoprolol for the safe and effective treatment of chronic heart failure.